28 344

Cited 0 times in

Serum hepatocyte growth factor as a marker of tumor activity in head and neck squamous cell carcinoma.

Kim, CH; Lee, JS; Kang, SO; Bae, JH; Hong, SP; Kahng, H
Oral oncology, 43(10):1021-1025, 2007
Journal Title
Oral oncology
Hepatocyte growth factor (HGF) has previously been reported to be elevated in the serum of patients with malignancy, including breast, colorectal and gastric cancers. Here, we evaluated the correlation between serum HGF and the progression of head and neck squamous cell carcinoma (HNSCC). The mean serum HGF levels in 71 healthy control subjects, 78 patients with primary HNSCC, and eight patients with recurrent HNSCC were 0.538+/-0.163, 0.701+/-0.252, and 0.925+/-0.349ng/ml, respectively. The increase in the HGF level was significantly correlated with tumor stage progression. The HGF level had decreased to normal at 1 month after curative resection of the tumors. During follow-up for several months, the HGF level significantly increased in recurrent HNSCC patients, whereas there was no increase in nonrecurrent patients. Our data suggest that serum HGF is significantly corrected with tumor progression and may be a strong predictor of recurrence in HNSCC.
MeSH terms
AdultAgedCarcinoma, Squamous Cell/blood*Carcinoma, Squamous Cell/secondaryCarcinoma, Squamous Cell/surgeryFemaleHead and Neck Neoplasms/blood*Head and Neck Neoplasms/surgeryHepatocyte Growth Factor/blood*HumansMaleMiddle AgedNeoplasm Recurrence, Local/bloodNeoplasm StagingTumor Markers, Biological/blood*
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Otolaryngology
AJOU Authors
김, 철호강, 성욱
Full Text Link
RIS (EndNote)
XLS (Excel)


해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.